FREE Daily Stock Alerts From Stock-PR.com
HONDO MINERALS CORP (OTCPK:HMNC)
HONDO MINERALS CORP (OTCPK:HMNC) recently announced that it has just acquired over $500,000 dollars of additional E-Leech equipment for its Tennessee Mine production facility. William R. Miertschin Chairman and CEO of Hondo Minerals say, "This purchase a long with the $2.4 million dollars of previously announced equipment demonstrates our continued efforts to invest real dollars in this project to increase shareholder value."
Mr. Miertschin went on to say, "All of this newly acquired equipment will allow the company the ability to reach its production and revenue targets 6 to12 months ahead of schedule, and with the advanced technology of E-Leech Hondo Minerals is posed to set new standards while obtaining optimum results from its exclusively licensed mining process."
E-Leech technology is a patent pending process that creates a leaching process without the use of hazardous chemicals such as cyanide at its Tennessee Mine processing plant. Toxic chemicals previously used such as Hydrochloric and Nitric Acid are replaced with a water-based and pH adjusted medium to leach precious and base metals from mine tailings that is safe to humans and the environment.
Electrochemical processes are used to generate pH levels low enough to leach metals such as Gold, Silver, Zinc and Rare Earths into a solution for recovery at an extremely low cost per ton.
Gold is a precious metal that has been mined for over two thousand years and at locations all across the globe. Such longevity and continued popularity must indicate that gold has that something special, and indeed it does. Gold is a highly adaptable material that is used across many different sectors and purposes, hence its continued usage centuries after it became so popular.
Gold is not, however, limited just to investment or jeweler. One of the primary uses of gold within the manufacturing sector is in electronics, such as electrical contacts in handheld devices and may other things. As it is incredibly conductive of electricity and resistant to damage from air or other chemicals, its usage ranges from space jet engine systems to simple USB cables. It is also used in very specialist instances, such as a very thin coating of gold across aircraft windscreens, through which electrical currents run, helping to keep them free of ice during flight. Gold's incredibly adaptability doesn't stop there; it is also used extensively in medicine and dentistry. Some isotopes of gold are part of a treatment for cancer patients and in the case of arthritis and other problems requiring anti-flammatories, gold can be injected into the patient.
Hondo Minerals Corporation is engaged in the acquisition of mines, mining claims and mining real estate in the United States, Canada and Mexico with mineral reserves of precious metals or non-ferrous metals.Hondo owns the Tennessee and Schuylkill Mines in Chloride, Arizona. The Tennessee Mine was the largest producing silver mine in Arizona history. The Tennessee Mine operated from the late 1800's until 1947 producing lead, zinc, gold and silver. The Company also owns numerous other mining claims in the US Southwest, which are being evaluated for additional reserves.
For more information please visit: http://www.hondominerals.com
Artio Global Investors Inc. (NYSE:ART) announced that Tony Williams, Chief Operating Officer, is scheduled to present at the Keefe, Bruyette & Woods Investment Management & Specialty Finance Conference in New York on Wednesday, June 8, 2011 at approximately 2:40 p.m. (Eastern Time). A live audio webcast of the presentation will be available on the Investor Relations page of our website at www.ir.artioglobal.com. An audio replay will also be available at the same web address shortly after the event.
Artio Global Investors, Inc. is a publicly owned asset management holding company. Through its subsidiary, the firm provides portfolio management and fund management services to its clients.
Interxion Holding NV (NYSE:INXN) announced that it is increasing its power supply by 1.5 MW in its Stockholm data centre, which will allow it to increase the available space capacity of the data centre by nearly 25%. The increase in space availability will help Interxion to meet demand for colocation space in its Stockholm Financial Hub which continues to gain critical mass by attracting interest from an array of financial services market participants. Customers can interconnect with their counterparties within the data centre at ultra-low latency and benefit from being able to quickly and efficiently change trading strategies when required.
InterXion Holding N.V. provides carrier-neutral colocation data center services in Europe. It enables its customers to connect to a range of telecommunications carriers, Internet service providers, and other customers.
Camelot Information Systems Inc. (NYSE:CIS) announced unaudited financial results for the first quarter ended March 31, 2011. Net revenues increased 51.7% year-over-year to US$53.6 million, compared to US$35.3 million in the first quarter of 2010. Adjusted operating income (1) increased 45.3% year-over-year to US$5.5 million from US$3.8 million in the first quarter of 2010. U.S. GAAP operating income increased 96.8% year-over-year to US$2.8 million from US$1.4 million in the first quarter of 2010. Adjusted net income (1) attributable to Camelot increased 48.3% year-over-year to US$5.1 million from US$3.4 million in the first quarter of 2010. U.S. GAAP net income attributable to Camelot increased 125.9% year-over-year to US$2.3 million from US$1.0 million in the first quarter of 2010. Adjusted diluted earnings (1) per American Depositary Share ("ADS") (2) were US$0.10, as compared to diluted earnings per ADS of US$0.09 in the first quarter of 2010. U.S. GAAP diluted earnings per ADS were US$0.05 in the first quarter of 2011, as compared to US$0.03 per ADS in the first quarter of 2010. One American Depositary Share ("ADS") represents four ordinary shares.
Camelot Information Systems Inc., through its subsidiaries, provides enterprise application services and financial industry information technology (NYSE:IT) services in the People’s Republic of China.
Power3 Medical Products, Inc. (OTC:PWRM)
Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroProÂ®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual's proteins to detect the presence of disease, a patient's disease progression, a patient's response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.
The NuroPro Blood Test is Power3's medical diagnostic tool for the early detection of Neurodegenerative diseases. The analysis is designed as a tool for physicians to diagnose various degenerative diseases of the brain and nervous system. The test involves monitoring the concentration of 59 proteins in blood serum to accurately detect and distinguish between Alzheimer's disease, ALS (Lou Gehrig's disease), and Parkinson's disease. Early detection of these diseases will allow physicians to intervene at an early stage to delay disease progression, potentially allowing patients to outlive their debilitating symptoms.
Alzheimer's disease is a progressive brain disorder that gradually destroys almost all cognitive functions: memory, learning, reason, judgment making, communication and ability to carry out daily activities. Alzheimer's research shows that genetics are a strong component to the development of the disease; and, although scientists are certain of the genetic link to Alzheimer's, they also recognize that environmental effects can play a role. Persons with a grandparent, parent, sibling or even child with Alzheimer's are subject to heightened risk for the disease. If more than one family member has Alzheimer's, risks are even greater.
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease).
Please visit Power3 Medical Products, Inc website http://www.power3medical.com.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (OTCPK:CRWE) has received twenty five thousand dollars ($25,000) in cash from a third party (Friona Gold, LLC) for 1 week of media advertisement services for Hondo Minerals Corporation (OTCPK:HMNC) Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM).
Sign Up For Free Stock Alerts At http://stock-pr.com/signup